TrialDrugs & aging2013

Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.

Anita Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.